Tumour model

HAL-01

XenograftIn vitro

Model characteristics

Organism
Human
Tissue of origin
B cells
Pathology
Model type
In vitro, Xenograft
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
B cells
Diffuse large B cells lymphoma DLBCL
XenograftIn vitro

A20

Mouse
B cells
Sarcoma
SyngeneicIn vitroResistant

DEL

Human
B cells
Diffuse large B cells lymphoma DLBCL
XenograftIn vitro
Human
B cells
Diffuse large B cells lymphoma DLBCL
XenograftIn vitro
Human
B cells
Diffuse large B cells lymphoma DLBCL
XenograftIn vitro

EB2

Human
B cells
Burkitt's lymphoma
XenograftIn vitro